David N. Gordon

Insider Reports History

Entity
Individual
Location
C/O Aclaris Therapeutics, Inc., 101 Lindenwood Drive, Suite 400, Malvern, PA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David N. Gordon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Chief Medical Officer Common Stock 147K $155K $1.05 Jul 13, 2021 Direct

Insider Reports Filed by David N. Gordon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Jul 13, 2021 1 -$44.7K 4 Jul 14, 2021 Chief Medical Officer
ACRS Aclaris Therapeutics, Inc. Jul 2, 2021 2 $0 4 Jul 7, 2021 Chief Medical Officer
ACRS Aclaris Therapeutics, Inc. Jun 1, 2021 6 -$1.14M 4 Jun 2, 2021 Chief Medical Officer